BIOXYTRAN, INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Bioxytran, Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Bioxytran, Inc Entity Common Stock, Shares Outstanding for the quarter ending October 25, 2024 was 85.8M shares, a 40.7% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 85.8M -58.9M -40.7% Oct 25, 2024 10-Q 2024-10-29
Q2 2024 178M +45.4M +34.3% Aug 14, 2024 10-Q 2024-08-14
Q1 2024 166M +43M +34.8% Mar 22, 2024 10-K 2024-03-22
Q3 2023 145M +21.6M +17.6% Nov 1, 2023 10-Q 2023-11-03
Q2 2023 133M +21.7M +19.6% Jul 28, 2023 10-Q 2023-07-31
Q1 2023 124M +12.7M +11.4% Mar 30, 2023 10-K 2023-03-31
Q3 2022 123M Nov 10, 2022 10-Q 2022-11-10
Q2 2022 111M +969K +0.88% May 19, 2022 10-Q 2022-05-23
Q1 2022 111M +10.1M +10% Apr 8, 2022 10-K 2022-04-11
Q4 2021 110M Nov 15, 2021 10-Q 2021-11-17
Q2 2021 110M +12.8M +13.2% Aug 10, 2021 10-Q 2021-08-10
Q1 2021 101M +12.7M +14.5% Apr 6, 2021 10-K 2021-04-09
Q3 2020 97.2M +10.7M +12.4% Nov 12, 2020 10-Q 2020-11-13
Q2 2020 97M +11.9M +14% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 88M +2.92M +3.43% Mar 13, 2020 10-K 2020-03-18
Q3 2019 86.5M +1.37M +1.61% Nov 12, 2019 10-Q 2019-11-13
Q2 2019 85.2M -25.3M -22.9% Aug 8, 2019 10-Q 2019-08-09
Q1 2019 85.1M -22.3M -20.8% Mar 11, 2019 10-K 2019-03-13
Q3 2018 85.1M +50.2M +144% Nov 7, 2018 10-Q 2018-11-08
Q2 2018 110M +75.5M +216% Jul 24, 2018 10-Q 2018-07-31
Q1 2018 107M +83.6M +351% May 15, 2018 10-Q 2018-05-15
Q4 2017 105M +74.2M +238% Dec 31, 2017 10-K 2018-04-02
Q3 2017 34.9M +6.75M +24% Nov 7, 2017 10-Q 2017-11-07
Q2 2017 34.9M +6.75M +24% Aug 14, 2017 10-Q 2017-08-14
Q1 2017 23.8M Mar 31, 2017 10-K 2017-03-31
Q4 2016 31.2M +3M +10.7% Dec 8, 2016 10-Q 2016-12-09
Q3 2016 28.2M +15.9M +129% Aug 22, 2016 10-Q/A 2016-09-20
Q2 2016 28.2M +22.4M +384% Aug 11, 2016 10-Q/A 2016-09-20
Q4 2015 28.2M +22.3M +384% Dec 31, 2015 10-K/A 2016-09-20
Q3 2015 12.3M -279M -95.8% Nov 12, 2015 10-Q 2015-11-12
Q2 2015 5.82M -180M -96.9% May 19, 2015 10-Q 2015-05-19
Q4 2014 5.82M -188M -97% Dec 31, 2014 10-K 2015-04-10
Q3 2014 291M +97M +50% Nov 12, 2014 10-Q 2014-11-13
Q2 2014 186M -113M -37.9% Aug 12, 2014 10-Q 2014-08-12
Q1 2014 186M +2.46M +1.34% May 14, 2014 10-Q 2014-05-14
Q4 2013 194M Dec 31, 2013 10-K 2014-04-14
Q3 2013 194M +52.8M +37.4% Nov 14, 2013 10-Q 2013-11-18
Q2 2013 299M +170M +132% Aug 9, 2013 10-Q 2013-08-15
Q1 2013 183M +64.2M +53.9% Mar 31, 2013 10-Q 2013-05-15
Q3 2012 141M -74.6B Sep 30, 2012 10-Q 2012-11-21
Q2 2012 129M +62.6M +94.5% Jun 30, 2012 10-Q/A 2013-01-22
Q1 2012 119M Mar 31, 2012 10-Q/A 2013-01-22
Q3 2011 74.7B* Sep 30, 2011 10-Q/A 2012-12-31
Q2 2011 66.2M Aug 11, 2011 10-Q/A 2012-12-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.